BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31330297)

  • 1. PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom.
    Avtaar Singh SS; DAS DE S; Rushton S; Berry C; Al-Attar N
    J Card Fail; 2019 Dec; 25(12):971-977. PubMed ID: 31330297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Consortium on Primary Graft Dysfunction: Redefining Clinical Risk Factors in the Contemporary Era of Heart Transplantation.
    Moayedi Y; Truby LK; Foroutan F; Han J; Guzman J; Angleitner P; Sabatino M; Felius J; VAN Zyl JS; Rodenas-Alesina E; Fan CP; Devore AD; Miller R; Potena L; Zuckermann A; Farrero M; Chih S; Farr M; Hall S; Ross HJ; Khush KK
    J Card Fail; 2024 Jun; 30(6):805-815. PubMed ID: 37907150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Avtaar Singh SS; Banner NR; Rushton S; Simon AR; Berry C; Al-Attar N
    Transplantation; 2019 Feb; 103(2):336-343. PubMed ID: 29757910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the International Society for Heart and Lung Transplantation (ISHLT) criteria for primary graft dysfunction after cardiac transplantation: outcomes from a high-volume centre†.
    Squiers JJ; Saracino G; Chamogeorgakis T; MacHannaford JC; Rafael AE; Gonzalez-Stawinski GV; Hall SA; DiMaio JM; Lima B
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):263-270. PubMed ID: 28186268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices.
    Truby LK; Takeda K; Topkara VK; Takayama H; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M
    J Heart Lung Transplant; 2018 Dec; 37(12):1433-1442. PubMed ID: 30206023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Severe Primary Graft Dysfunction in Infants Following Heart Transplant.
    Singh TP; Profita EL; Rycus P; Thiagarajan R; Gauvreau K
    J Am Heart Assoc; 2021 Jul; 10(13):e021082. PubMed ID: 34184543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    Takeda K; Li B; Garan AR; Topkara VK; Han J; Colombo PC; Farr MA; Naka Y; Takayama H
    J Heart Lung Transplant; 2017 Jun; 36(6):650-656. PubMed ID: 28087104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation.
    Kawabori M; Mastroianni MA; Zhan Y; Chen FY; Rastegar H; Warner KG; Reich JA; Vest A; DeNofrio D; Couper GS
    J Artif Organs; 2020 Jun; 23(2):140-146. PubMed ID: 31713054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Power Output Index and Severe Primary Graft Dysfunction After Heart Transplantation.
    Lim HS; Ranasinghe A; Chue C; Quinn D; Mukadam M; Mascaro J
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):398-403. PubMed ID: 32747204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition.
    Dronavalli VB; Rogers CA; Banner NR
    Transplantation; 2015 Sep; 99(9):1919-25. PubMed ID: 25742423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant.
    Benck L; Kransdorf EP; Emerson DA; Rushakoff J; Kittleson MM; Klapper EB; Megna DJ; Esmailian F; Halprin C; Trento A; Ramzy D; Czer LSC; Chang DH; Ebinger JE; Kobashigawa JA; Patel JK
    J Heart Lung Transplant; 2021 Sep; 40(9):970-980. PubMed ID: 34272125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.
    Jacob S; Lima B; Gonzalez-Stawinski GV; El-Sayed Ahmed MM; Patel PC; Belli EV; Makey IA; Thomas M; Landolfo K; Landolfo C; Leoni Moreno JC; Yip DS; Pham SM
    Clin Transplant; 2019 May; 33(5):e13538. PubMed ID: 30870577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor serum SMARCAL1 concentrations predict primary graft dysfunction in cardiac transplantation.
    Aharinejad S; Andrukhova O; Gmeiner M; Thomas A; Aliabadi A; Zuckermann A; Krenn K; Grimm M
    Circulation; 2009 Sep; 120(11 Suppl):S198-205. PubMed ID: 19752368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction.
    Kransdorf EP; Rushakoff JA; Han J; Benck L; Malinoski D; Emerson D; Catarino P; Rampolla R; Kobashigawa JA; Khush KK; Patel JK
    J Heart Lung Transplant; 2023 May; 42(5):617-626. PubMed ID: 36682894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.
    Truby LK; Kwee LC; Agarwal R; Grass E; DeVore AD; Patel CB; Chen D; Schroder JN; Bowles D; Milano CA; Shah SH; Holley CL
    J Heart Lung Transplant; 2021 Dec; 40(12):1589-1598. PubMed ID: 34511330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and survival impact of primary graft dysfunction after lung transplantation in a single institution.
    Samano MN; Fernandes LM; Baranauskas JC; Correia AT; Afonso JE; Teixeira RH; Caramori ML; Pêgo-Fernandes PM; Jatene FB
    Transplant Proc; 2012 Oct; 44(8):2462-8. PubMed ID: 23026621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.
    Lozano-Edo S; Sánchez-Lázaro I; Portolés M; Roselló-Lletí E; Tarazón E; Arnau-Vives MA; Ezzitouny M; Lopez-Vilella R; Almenar-Bonet L; Martínez-Dolz L
    Transplantation; 2022 Apr; 106(4):887-893. PubMed ID: 33901112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal life support for primary graft dysfunction after heart transplantation.
    Pozzi M; Bottin C; Armoiry X; Sebbag L; Boissonnat P; Hugon-Vallet E; Koffel C; Flamens C; Paulus S; Fellahi JL; Obadia JF
    Interact Cardiovasc Thorac Surg; 2018 Nov; 27(5):778-784. PubMed ID: 29788286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.